Shanghai Henlius Biotech, Inc. Class H Financial Overview
Shanghai Henlius Biotech, Inc. Class H's market cap is currently HK$34.13B. The company's EPS TTM is HK$; its P/E ratio is 38.35; Shanghai Henlius Biotech, Inc. Class H is scheduled to report earnings on August 25, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
